IDDF2022-ABS-0253 Dietary Additive Carrageenan Metabolized by Human GUT Microbiota and Promoting Colorectal Cancer

Xueliang Wang,Yi Fang,Wei Liang,Meinong Liang,Lixia Xu,Jun Yu

DOI: https://doi.org/10.1136/gutjnl-2022-iddf.79

IF: 24.5

2022-01-01

Gut

Abstract:Background Emerging evidence implicates a significant role of food additives in colorectal cancer (CRC). The threat of degraded kappa-carrageenan (dCGN) to CRC remains controversial. dCGN can’t be metabolized by human intrinsic enzymes and gut microbiota may be a breakthrough. Methods Raman-activated cell sorting (RACS) was used to reveal the key bacteria metabolizing dCGN in the human intestinal tract. Microbiota-mediated dCGN on promoting CRC was assessed in various models of CRC, including germ-free mice and transgenic mice. CRC cell lines were co-cultured with the dCGN bacterial metabolic supernatant to evaluate cell proliferation, apoptosis and cell cycle. Key metabolite produced by the interaction between gut microbiota and dCGN were identified by targeted mass spectrometry. Results dCGN significantly increased the incidence rate of high-grade dysplasia (from 20% to 60%) and tumor (from 0% to 40%) in the single-dose AOM-induced CRC mice model. RACS and function test demonstrated that E.coli ST871 from healthy men’s stool could efficiently metabolize dCGN in vitro. The supernatant that E.coli ST871 fermented dCGN significantly promoted cell proliferation and colony formation in CRC cells, but not in normal colon epithelial cells. The Apcmin/+ mice gavaged with dCGN and E.coli ST871 significantly increased tumor incidence (from 25% to 80%) and tumor number compared with the dCGN-free group. In addition, E.coli ST871 significantly increased the proportion of dCGN-induced dysplasia in colons of germ-free mice. Using LC-MS/MS, enrichment of pyrocatechol was identified in both culture-supernatant and the feces of E.coli ST871 combined with dCGN treated germ mice. Pyrocatechol displayed pro-CRC effects in vitro and in vivo. Conclusions dCGN promotes colon tumorigenesis by human intestinal strain E.coli ST871 mediated metabolite pyrocatechol.